Literature DB >> 19451424

Soft tissue sarcoma trials: one size no longer fits all.

Jaap Verweij.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19451424     DOI： 10.1200/JCO.2009.21.8180

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Moving beyond response criteria: new measures of success in the treatment of sarcomas.

Authors:  Andrew E Hendifar; Elke Ahlmann; Daniel C Allison; James Hu; Lawrence Menendez; Sant P Chawla
Journal:  Curr Treat Options Oncol       Date:  2012-09

2.  Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression.

Authors:  Beverly A Teicher; Eric Polley; Mark Kunkel; David Evans; Thomas Silvers; Rene Delosh; Julie Laudeman; Chad Ogle; Russell Reinhart; Michael Selby; John Connelly; Erik Harris; Anne Monks; Joel Morris
Journal:  Mol Cancer Ther       Date:  2015-09-08       Impact factor: 6.261

Review 3.  Salvage Therapy in Advanced Adult Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis of Randomized Trials.

Authors:  Alessandro Comandone; Fausto Petrelli; Antonella Boglione; Sandro Barni
Journal:  Oncologist       Date:  2017-08-23

4.  Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma.

Authors:  S Tariq Mahmood; Samuel Agresta; Carlos E Vigil; Xiuhua Zhao; Gang Han; Gina D'Amato; Ciara E Calitri; Michelle Dean; Christopher Garrett; Michael J Schell; Scott Antonia; Alberto Chiappori
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

5.  The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB.

Authors:  H Jacobs; A Bast; G J Peters; W J F van der Vijgh; G R M M Haenen
Journal:  Br J Cancer       Date:  2011-01-18       Impact factor: 7.640

Review 6.  Recent advances in understanding and managing leiomyosarcomas.

Authors:  Florence Duffaud; Isabelle Ray-Coquard; Sébastien Salas; Patricia Pautier
Journal:  F1000Prime Rep       Date:  2015-05-12

Review 7.  Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin.

Authors:  Frédéric Amant; Domenica Lorusso; Alexander Mustea; Florence Duffaud; Patricia Pautier
Journal:  Sarcoma       Date:  2015-05-18

Review 8.  Current status and perspectives of patient-derived rare cancer models.

Authors:  Tadashi Kondo
Journal:  Hum Cell       Date:  2020-06-14       Impact factor: 4.174
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.